ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Marker Therapeutics Awarded $13.1 Million Grant from the Cancer Prevention and Research Institute of Texas
August 20, 2021Marker today announced that the Company received notice of a Product Development Research award totaling approximately $13.1 million from the CPRIT to support the Company's Phase 2 clinical trial of its lead MultiTAA-specific T cell product MT-401. -
Marker Therapeutics Announces Opening of New cGMP Manufacturing Facility
August 02, 2021Marker Therapeutics, Inc. announced that the Company's new cGMP manufacturing facility in Houston, TX, located near the George Bush Intercontinental Airport, is fully operational. -
Marker Therapeutics Appoints Regulatory Affairs VP
August 19, 2019Dr. Agopyan brings more than 15 years of industry knowledge in regulatory affairs and clinical development.
Pharma Sources Insight January 2025
